High expression of PRMT5 has been observed in prostate cancer, pancreatic cancer, gastric cancer, etc. Overexpression of PRMT5 is related to the metabolism of cancer cells, can promote the progression and metastasis of cancer, and is related to a poor prognosis in cancer patients [135,136,137,138,139]. This evidence concerns the gene PRMT5 and prostate carcinoma.